Position in VTRS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,940
-$17 QoQ
Shares Held
500
-15.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#785
of 1,016 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BFSG, LLC holds $456,423 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
8,842 | $217,601 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,567 | $154,729 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
14,905 | $73,481 | |
| 4 | VTRS |
Viatris Inc
This page
|
500 | $7,940 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10 | $1,685 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
200 | $898 | |
| 7 | ACB |
Aurora Cannabis Inc
|
32 | $89 |
All Filings in VTRS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,940 | 500 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,957 | 589 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $7,333 | 589 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $5,336 | 539 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,465 | 500 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $4,355 | 500 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $6,225 | 500 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,944 | 512 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $5,315 | 500 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,970 | 500 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,415 | 500 | Shares | Sole | 2024-04-23 | |
| No filing history on record for this holder in this stock. | ||||||